Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Optic neuropathy after retrobulbar neuritis in multiple sclerosis : Are optical coherence tomography and magnetic resonance imaging useful and necessary follow-up parameters?].
EP2 Receptor Signaling Regulates Microglia Death.
Human oligodendrocytes in remyelination research.
Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.
Disease activity and disability evolution under glatiramer acetate: A clinical approach.
Disability in multiple sclerosis: When synaptic long-term potentiation fails.
Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter.
Prospect of brain-machine interface in motor disabilities: the future support for multiple sclerosis patient to improve quality of life.
The impact of neuromyelitis optica on the recognition of emotional facial expressions: A preliminary report.
FDA warns about the risks of unproven surgical therapy for multiple sclerosis.
Multiple sclerosis drug fingolimod receives new safety warnings related to cardiovascular risk.
[Cognitive deficits and dementia in patients with multiple sclerosis: status quo and open questions].
IL-12, but not IL-23, induces the expression of IL-7 in microglia and macrophages: Implications for multiple sclerosis.
Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically relevant association?
JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients.
Sunshine and multiple sclerosis.
Anti-IL-17A Treatment Reduces Clinical Score and VCAM-1 Expression Detected by in Vivo Magnetic Resonance Imaging in CR-EAE ABH Mice.
Alemtuzumab for multiple sclerosis.
A case of exacerbated multiphasic disseminated encephalomyelitis after interferon beta treatment.
Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction.
Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.
Fulminant Demyelinating Diseases of the Central Nervous System.
Associated Inosine to interferon: results of a clinical trial in multiple sclerosis.
Association of Cerebrospinal Fluid Levels of Lateral Olfactory Tract Usher Substance (LOTUS) With Disease Activity in Multiple Sclerosis.

Pages